[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 1125489, "exercisedValue": 0, "unexercisedValue": 657452}, {"maxAge": 1, "name": "Ms. Daniella  Beckman CPA", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 717616, "exercisedValue": 0, "unexercisedValue": 337565}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Legal Officer, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 674222, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 882167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Alan  Ashworth FRS, Ph.D.", "age": 63, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 57, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Head of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth Pingpank Hickin", "title": "VP of IR & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 4.8, "open": 4.9, "dayLow": 4.7, "dayHigh": 5.225, "regularMarketPreviousClose": 4.8, "regularMarketOpen": 4.9, "regularMarketDayLow": 4.7, "regularMarketDayHigh": 5.225, "payoutRatio": 0.0, "beta": 1.244, "forwardPE": -3.633803, "volume": 2118944, "regularMarketVolume": 2024575, "averageVolume": 2392898, "averageVolume10days": 3617650, "averageDailyVolume10Day": 3617650, "bid": 3.71, "ask": 6.06, "bidSize": 2, "askSize": 2, "marketCap": 559313024, "fiftyTwoWeekLow": 1.03, "fiftyTwoWeekHigh": 12.015, "priceToSalesTrailing12Months": 13.645109, "fiftyDayAverage": 2.2981, "twoHundredDayAverage": 3.740875, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 379536032, "profitMargins": 0.0, "floatShares": 39979029, "sharesOutstanding": 108394000, "sharesShort": 15954703, "sharesShortPriorMonth": 12554952, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.1472, "heldPercentInsiders": 0.12587, "heldPercentInstitutions": 0.97747004, "shortRatio": 4.87, "shortPercentOfFloat": 0.1775, "impliedSharesOutstanding": 108394000, "bookValue": 1.542, "priceToBook": 3.3463032, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -132264000, "trailingEps": -1.2, "forwardEps": -1.42, "enterpriseToRevenue": 9.259, "enterpriseToEbitda": -2.647, "52WeekChange": -0.4916256, "SandP52WeekChange": 0.09544468, "quoteType": "EQUITY", "currentPrice": 5.16, "targetHighPrice": 13.0, "targetLowPrice": 8.0, "targetMeanPrice": 10.42857, "targetMedianPrice": 10.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 216724000, "totalCashPerShare": 1.999, "ebitda": -143374000, "totalDebt": 36946000, "quickRatio": 6.034, "currentRatio": 6.262, "totalRevenue": 40990000, "debtToEquity": 22.156, "revenuePerShare": 0.373, "returnOnAssets": -0.26794, "returnOnEquity": -0.61346, "grossProfits": -101305000, "freeCashflow": -67248752, "operatingCashflow": -135340992, "revenueGrowth": -0.167, "grossMargins": -2.4714599, "ebitdaMargins": 0.0, "operatingMargins": -7.88761, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1750462685, "regularMarketTime": 1750449600, "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "regularMarketChangePercent": 7.49999, "regularMarketPrice": 5.16, "postMarketChangePercent": 0.0, "postMarketPrice": 5.16, "postMarketChange": 0.0, "regularMarketChange": 0.36, "regularMarketDayRange": "4.7 - 5.225", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2392898, "fiftyTwoWeekLowChange": 4.13, "fiftyTwoWeekLowChangePercent": 4.009709, "fiftyTwoWeekRange": "1.03 - 12.015", "fiftyTwoWeekHighChange": -6.8550005, "fiftyTwoWeekHighChangePercent": -0.57053685, "cryptoTradeable": false, "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekChangePercent": -49.16256, "earningsTimestamp": 1747047602, "earningsTimestampStart": 1754397000, "earningsTimestampEnd": 1754915400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.2, "epsForward": -1.42, "epsCurrentYear": -1.3445, "priceEpsCurrentYear": -3.837858, "fiftyDayAverageChange": 2.8618999, "fiftyDayAverageChangePercent": 1.2453331, "twoHundredDayAverageChange": 1.4191248, "twoHundredDayAverageChangePercent": 0.37935638, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-06-21"}]